Category: Antibody Technologies
Global Antibody Technologies
-
Global Peripheral Blood Mononuclear Cells Market Assessment, By Product [Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, PBMC Isolation & Viability Kits], By Application [Immunology, Hematology, Vaccine Development, Toxicology, Infectious Disease, others], By Techniques [Density Gradient Centrifugation, Leukapheresis, Others], By Source [Human, Animal], By Region, Opportunities, and Forecast, 2016-2030F
... Gradient Centrifugation, Leukapheresis, Others], By Source [Human, Animal], By Region, Opportunities, and Forecast, 2016-2030F The Global Peripheral Blood Mononuclear Cells (PBMCs) Market is projected to reach USD 273.28 million by 2030 from USD 589.84 million ... Read More
-
Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End Users (Diagnostic laboratories, Research Institute) - Global Forecast to 2028
... reach USD 4.7 billion by 2028 from USD 3.2 billion in 2023, at a CAGR of 7.4% during the forecast period of 2023 to 2028. Market growth is largely driven by increased prevalence of cancer ... Read More
-
Global MMP13 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel MMP13 antibody drugs, increasing penetration rate of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in ... Read More
-
Global HDAC2 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel HDAC2 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in HDAC2 ... Read More
-
Global S100A11 Antibody Market Growth 2023-2029
... % from 2023 to 2029. The growing patient base, the launch of novel S100A11 antibody drugs, the increasing penetration rate of antibody drugs, and the continuous regulation of the entire biopharmaceutical industry are the key ... Read More
-
Global HMGB1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel HMGB1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue ... Read More
-
Global CD31 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel CD31 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in CD31 ... Read More
-
Global C-EBP Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel C/EBP antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth of C/EBP ... Read More
-
Global Anti-NeuN Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel anti-neuronal antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue ... Read More
-
Global EEA1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel EEA1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in revenue ... Read More
-
Global AQP4 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel AQP4 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in AQP4 ... Read More
-
Global HP1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of novel HP1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in HP1 ... Read More
-
Immunohistochemistry Market Forecasts to 2028 – Global Analysis By Product (Kits, Antibody, Equipment and Reagents), Distribution channel (Research Applications, Diagnosis and Forensic) and End User and By Geography
... Market is accounted for $2.60 billion in 2022 and is expected to reach $4.24 billion by 2028 growing at a CAGR of 8.5% during the forecast period. Immunohistochemistry is critical for biomarker development. Immunohistochemistry is ... Read More
-
Global Anti Cyclic Citrullinated Peptide(Anti-CCP) Antibody Assay Kit Supply, Demand and Key Producers, 2023-2029
... a market growth of % CAGR during the forecast period (2023-2029). Anti Cyclic Citrullinated Peptide(Anti-CCP) Antibody Assay Kit is used to detect the presence of anti-cyclic citrulline polypeptide antibodies. Rheumatoid arthritis (RA) is a common ... Read More
-
Global Anti Cyclic Citrullinated Peptide(Anti-CCP) Antibody Assay Kit Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... Kit market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and ... Read More
-
Global ALPP Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of ALPP antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in ALPP antibody ... Read More
-
Global ACSL1 Antibody Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. Growing patient base, launch of novel ACSL1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the ... Read More
-
Global 53BP1 Antibody Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. Growing patient base, launch of novel 53BP1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the ... Read More
-
Global 4E-BP1 Antibody Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. Growing patient base, launch of novel 4E-BP1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the ... Read More
-
Global RAB27B Antibody Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. Growing patient base, launch of novel RAB27B antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the ... Read More
-
Global Bevacizumab Monoclonal Antibody Biosimilar Market Growth 2023-2029
... to grow at a CAGR of -15.0% from 2023 to 2029. United States market for Bevacizumab Monoclonal Antibody Biosimilar is estimated to increase from US$ million in 2022 to US$ million by 2029, at a ... Read More
-
Global CSN2 Antibody Market Growth (Status and Outlook) 2023-2029
... a CAGR of % from 2023 to 2029. Growing patient base, launch of new CSN2 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the ... Read More
-
Global PPT1 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of PPT1 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in PPT1 antibody ... Read More
-
Global Mre11 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of Mre11 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in Mre11 antibody ... Read More
-
Global SKP2 Antibody Market Growth 2023-2029
... % from 2023 to 2029. Growing patient base, launch of ALPP antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in ALPP antibody ... Read More
Research Assistance
